There Seems To Me To Be A Difference In Treatment In The UK To The USA I Do Not Have A Clue What My Numbers Are I Was Told At The Beginning.
I only know I have I think lg kappa and light chains.
I have IGG KAPPA Myeloma
Had initial treatment from August 2015 thru December 2015 then had a stem cell transplant in January 2016. Went into remission for 7 1/2 years I was on maintenance of velcade then changed to ninlaro during covid. Started a new treatment for relapsed mm in Nov 2023 of pomalyst 4mg and Dara faspro along with 20 mg of dexamethasone. As of June 2024 my m spike is 0 kappa light chains are in the normal range. I get monthly Dara faspro injections and the pomalyst is now 2mg 21 days on 7 days off. I also get monthly ivig as the pomalyst brings down my immunoglobulins below normal. I get monthly lab tests.
Thank you the last two consultations being every 3 months I am told she has not had my light chains results back and my kidney down to 57 per cent.So I will have to push her for some clarity.
Ask your doctor. It looks like you might be IgG Kappa myeloma? IgG being the heavy chain and Kappa being the light chain. I don't know without seeing your chart. The US and UK uses different units of measure for labs. Liters vs deciliters for example.
I couldn't have a stem cell treatment due to adverse reactions to medication it is good your doctors are on it here at the moment huge backlogs because of strikes.
It sounds like you're concerned about differences in myeloma treatment between the UK and the USA and are unsure about your specific health metrics. Here are some steps you can take to better understand and manage your myeloma treatment:
1. Know Your Policy: Understand the details of your insurance policy, including read more
This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.
Kappa Light Chains- Anyone Else Have This As Their Only Sign Of MM?
Who To Consult With.....
Is There A Difference Between An Oncologist And A Referring Oncologist?